Digestive Enzymes Market By Origin (Animal, Microbial, Plant), By Enzyme Type (Carbohydrase, Protease, Lipase, Other Enzyme Types), By Applications (Prescription Medicine, Sports Nutrition, Infant Nutrition): Global Opportunity Analysis and Industry Forecast, 2021-2031
The digestive enzymes market was valued at $699.4 million in 2021, and is projected to reach $1,643.6 million by 2031, registering a CAGR of 8.7% from 2022 to 2031.
Digestive enzymes break down proteins, carbohydrates, and lipids and their supplementation play a role in management of digestive disorders, from lactose intolerance to cystic fibrosis. Several formulations of digestive enzymes are available in the market, being different from each other in terms of enzyme type, source & origin, and dosage. Animals-derived enzymes represent an established standard of care. However, the growing study of plants-based and microbe-derived enzymes offer great advancements of digestive enzyme therapy. Moreover, pancreatic enzyme supplementation is the therapy of choice for management of exocrine pancreatic insufficiency (EPI) in chronic pancreatitis, pancreatic cancer, cystic fibrosis (CF), or diabetes. Required daily dose of enzymes is variable, being related to etiology and severity of clinical features of patients, such as age & body weight and for cystic fibrosis, genotype and intestinal factors affect absorption.
The digestive enzymes market trends like increase in prevalence of digestive problems, increase in unhealthy lifestyle by population, and rise in geriatric population are key factors that fuel growth of the digestive enzyme market. Moreover, surge in number of fitness centers and gymnasiums has also increased demand for dietary supplements, increase in awareness about GI health, and focus on preventive disease management are other factors that contribute toward growth of the market. However, lack of knowledge regarding appropriate dosage amounts and presence of substitutes for digestive enzyme supplements are expected to hinder growth of the market. Conversely, development of customized digestive enzymes offer lucrative opportunities for growth of the market.
The digestive enzymes market is segmented into origin, enzyme type, application, and region. By origin, the market is categorized into animals, microbial, and plants. Further, the animals segment is categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition segment for animals is classified into sports drink and other sport supplements. Further, the microbial segment is categorized into prescription medicine, sports nutrition, and infant nutrition. In addition, the sports nutrition segment for microbial is classified into sports drink and other sport supplements. The plants segment is further categorized into prescription medicine, sports nutrition, and infant nutrition. The sports nutrition for plants is classified into sports drink and other sport supplements. By enzyme type, the market is divided into carbohydrase, protease, lipase, and others. By application, it is divided into prescription medicine, sports nutrition, and infant nutrition. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).
Major companies profiled in the report include Abbott Laboratories, AbbVie Inc., Amway Corporation, Archer Daniels Midland Company, Biotics Research Corporation, Brain Group Co Ltd., Country Life, LLC, Douglas Laboratories, Garden of Life, International Flavors & Fragrances Inc, Johnson & Johnson, Metagenics Inc., Mimi's Rock Corporation, Otsuka Holding Co ltd, Soho Flordis International Health, The Enzymedica Group, Vox Nutrition.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive enzymes market analysis from 2021 to 2031 to identify the prevailing digestive enzymes market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the digestive enzymes market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global digestive enzymes market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Origin
Animal
Microbial
Plant
By Enzyme Type
Carbohydrase
Protease
Lipase
Other Enzyme Types
By Applications
Prescription Medicine
Sports Nutrition
Infant Nutrition
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Allergan PLC
Abbvie Inc.
Amway Corporation
Country Life LLC.
Garden Of Life Inc.
Biotics Research Corporation
Metagenics, Inc.
Abbott Nutrition.
Johnson & Johnson
Archer Daniels Midland Company (DeerLand Enzymes)
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook